Australasian Leukaemia & Lymphoma Group (ALLG)
Sukhjiwan Kaur is a Clinical Research Associate II at Australasian Leukaemia & Lymphoma Group (ALLG). Prior to this, they have held positions as Clinical Research Associate at DOCS-Amgen, Clinical Trial Associate at DOCS-FSP Amgen, Study Coordinator at Chris O'Brien Lifehouse, and Scientist at Douglas Hanly Moir Pathology lab. Sukhjiwan Kaur holds a Bachelor of Biomedical Science in Forensic Biology from the University of Technology Sydney.
This person is not in the org chart
Australasian Leukaemia & Lymphoma Group (ALLG)
Since 1973, the ALLG and its members have delivered world-class clinical trials and continue to advance the treatment, care and quality of life for patients with blood cancer. The ALLG’s National Blood Cancer Registry (NBCR) is the largest holding of real-world acute myeloid leukaemia (AML) data in Australia and New Zealand. Connect with us today to learn more about how we deliver better treatments and better lives through our range of collaborative clinical trials and translational research initiatives.